However, in RB-treated glioma cells, we found that Ca2+ was significantly elevated after activation of Na+-K+-ATPase by RB, which inhibited the Src/FAK/Paxillin focal adhesion pathway. This evidence concerns the gene RB1 and central nervous system cancer.